Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
fda
3
×
life sciences
national blog main
national top stories
roche
3
×
san francisco blog main
san francisco top stories
biotech
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
larotrectinib
loxo oncology
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avapritinib
What
cancer
3
×
drug
3
×
fda
ahead
ambien
american
annual
approval
approved
asco
attendees
attention
biotech
blueprint
camp’s
candidate
cash
chicago
city
clinical
combinations
community’s
currently
days
deeper
dna
expanding
fingerprint
focus
genetic
going
home
key
kicks
marketing
matter
medicine
medicines
meeting
muscle
Language
unset
Current search:
fda
×
drug
×
cancer
×
roche
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More